Sorafekast — Sorafenib 200 mg Tablets

Prescribed by oncologists for the treatment of:

• 🔹 Hepatocellular Carcinoma (HCC): Unresectable liver cancer.
• 🔹 Renal Cell Carcinoma (RCC): Advanced kidney cancer, especially when other therapies have failed.
• 🔹 Differentiated Thyroid Carcinoma: Progressive thyroid cancer that no longer responds to radioactive iodine treatment.

Sales Unit: 1 Bottle (120 Tablets).

⚠️ STRICTLY BY PRESCRIPTION:

• Standard Dosage: Typically 400 mg (2 tablets) twice daily (Total daily dose: 800 mg).
• Administration: Swallow tablets whole with a glass of water.
• Food Interaction: Take on an empty stomach (1 hour before eating) or with a low-fat meal. High-fat meals reduce bioavailability!
• Duration: Treatment continues as long as clinical benefit is observed or until toxicity occurs.

• ⛔ Pregnancy & Breastfeeding: Can cause fetal harm. Strict contraception is required.
• Severe hypersensitivity to Sorafenib.
• Children and adolescents (safety not established).
• Use with caution in patients with cardiac conditions (QT prolongation), hypertension, or bleeding disorders.

Common side effects (require medical monitoring):

• ✋🦶 Hand-Foot Skin Reaction: Redness, pain, or peeling of palms and soles.
• 📉 Diarrhea, fatigue, weight loss.
• 🩸 Hypertension (high blood pressure).
• 🤕 Hair thinning or loss (alopecia).